Kevin Andrew Bess, CAA | |
1 Shircliff Way, Jacksonville, FL 32204-4748 | |
(904) 308-7300 | |
Not Available |
Full Name | Kevin Andrew Bess |
---|---|
Gender | Male |
Speciality | Anesthesiology Assistant |
Experience | 5 Years |
Location | 1 Shircliff Way, Jacksonville, Florida |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1497301535 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
367H00000X | Anesthesiologist Assistant | (* (Not Available)) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Ascension St Vincent's Clay County | Middleburg, FL | Hospital |
Ascension St Vincent's Riverside | Jacksonville, FL | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
North Florida Anesthesia Consultants Inc | 7416869565 | 114 |
News Archive
"Sepsis affects approximately 750,000 patients each year in the United States and is in many ways a model condition for examining the relationship between hospital spending and patient outcomes and for identifying potential opportunities to improve the value of hospital care," write the authors.
The GAVI Alliance "has put on hold some $6 million earmarked for Sierra Leone after an audit showed misuse of previous funds, a document seen by Reuters showed," Reuters reports.
In agreement with the U.S. Food and Drug Administration (FDA), Bayer HealthCare Pharmaceuticals Inc. today announced that it has updated the labels for its drospirenone-containing combination oral contraceptives (COCs) in the United States.
Today, Pharmanest AB announced that the first patient has been dosed in a randomized Phase II study of SHACT, a product developed for pain relief associated with intrauterine device (IUD) insertion. Karolinska Development AB (STO:KDEV) owns 58.9 percent of Pharmanest.
› Verified 5 days ago
Entity Name | North Florida Anesthesia Consultants Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1346236866 PECOS PAC ID: 7416869565 Enrollment ID: O20031105000664 |
News Archive
"Sepsis affects approximately 750,000 patients each year in the United States and is in many ways a model condition for examining the relationship between hospital spending and patient outcomes and for identifying potential opportunities to improve the value of hospital care," write the authors.
The GAVI Alliance "has put on hold some $6 million earmarked for Sierra Leone after an audit showed misuse of previous funds, a document seen by Reuters showed," Reuters reports.
In agreement with the U.S. Food and Drug Administration (FDA), Bayer HealthCare Pharmaceuticals Inc. today announced that it has updated the labels for its drospirenone-containing combination oral contraceptives (COCs) in the United States.
Today, Pharmanest AB announced that the first patient has been dosed in a randomized Phase II study of SHACT, a product developed for pain relief associated with intrauterine device (IUD) insertion. Karolinska Development AB (STO:KDEV) owns 58.9 percent of Pharmanest.
› Verified 5 days ago
Mailing Address | Practice Location Address |
---|---|
Kevin Andrew Bess, CAA 5473 Cork Oak St, Sarasota, FL 34232-3058 Ph: (941) 400-2876 | Kevin Andrew Bess, CAA 1 Shircliff Way, Jacksonville, FL 32204-4748 Ph: (904) 308-7300 |
News Archive
"Sepsis affects approximately 750,000 patients each year in the United States and is in many ways a model condition for examining the relationship between hospital spending and patient outcomes and for identifying potential opportunities to improve the value of hospital care," write the authors.
The GAVI Alliance "has put on hold some $6 million earmarked for Sierra Leone after an audit showed misuse of previous funds, a document seen by Reuters showed," Reuters reports.
In agreement with the U.S. Food and Drug Administration (FDA), Bayer HealthCare Pharmaceuticals Inc. today announced that it has updated the labels for its drospirenone-containing combination oral contraceptives (COCs) in the United States.
Today, Pharmanest AB announced that the first patient has been dosed in a randomized Phase II study of SHACT, a product developed for pain relief associated with intrauterine device (IUD) insertion. Karolinska Development AB (STO:KDEV) owns 58.9 percent of Pharmanest.
› Verified 5 days ago
Alyssa Kay Burgo, Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 800 Prudential Dr, Jacksonville, FL 32207 Phone: 904-202-2000 | |
Haley Wingo, CAA Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 800 Prudential Dr, Jacksonville, FL 32207 Phone: 904-202-8000 | |
Mr. Kyle Matthew Hillis, CAA Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 820 Prudential Dr Ste 606, Jacksonville, FL 32207 Phone: 904-398-3356 | |
April Jennifer Harris Still, AAC Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 655 W 8th St, Jacksonville, FL 32209 Phone: 904-244-3660 | |
Benjamin Olson Dickey, CAA Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 800 Prudential Dr, Jacksonville, FL 32207 Phone: 904-202-2000 | |
Olga B Carroll, AA Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 655 W 8th St, Jacksonville, FL 32209 Phone: 904-244-0411 | |
William James Morgan, Anesthesiologist Assistant Medicare: Medicare Enrolled Practice Location: 800 Prudential Dr, Jacksonville, FL 32207 Phone: 904-202-2000 |